Granahan Investment Management, LLC Macrogenics Inc Transaction History

Granahan Investment Management, LLC

$2.38 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$8.12 - $16.9 $1.62 Million - $3.37 Million	-199,541 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$15.91 - $21.88 $501,435 - $689,591	-31,517 Reduced 13.64%	199,541 $3.2 Million
Q3 2021 Nov 15, 2021	SELL	$19.74 - $28.7 $560,300 - $814,620	-28,384 Reduced 10.94%	231,058 $4.84 Million
Q2 2021 Aug 16, 2021	BUY	$20.49 - $35.63 $290,240 - $504,698	14,165 Added 5.78%	259,442 $6.97 Million
Q1 2021 May 17, 2021	SELL	$18.99 - $33.2 $846,650 - $1.48 Million	-44,584 Reduced 15.38%	245,277 $7.81 Million
Q4 2020 Feb 12, 2021	BUY	$19.41 - $26.0 $2.06 Million - $2.76 Million	105,986 Added 57.64%	289,861 $6.63 Million
Q3 2020 Nov 12, 2020	SELL	$24.69 - $31.6 $869,853 - $1.11 Million	-35,231 Reduced 16.08%	183,875 $4.63 Million
Q2 2020 Aug 14, 2020	SELL	$5.2 - $29.12 $28,766 - $161,091	-5,532 Reduced 2.46%	219,106 $6.12 Million
Q1 2020 May 12, 2020	SELL	$4.28 - $12.11 $5,619 - $15,900	-1,313 Reduced 0.58%	224,638 $1.31 Million
Q4 2019 Feb 14, 2020	BUY	$7.95 - $12.27 $13,475 - $20,797	1,695 Added 0.76%	225,951 $2.46 Million
Q3 2019 Nov 15, 2019	BUY	$12.44 - $17.48 $122,422 - $172,020	9,841 Added 4.59%	224,256 $2.86 Million
Q2 2019 Aug 14, 2019	SELL	$14.51 - $19.71 $193,041 - $262,221	-13,304 Reduced 5.84%	214,415 $3.64 Million
Q1 2019 May 14, 2019	SELL	$11.11 - $25.6 $141,863 - $326,886	-12,769 Reduced 5.31%	227,719 $4.09 Million
Q4 2018 Feb 13, 2019	SELL	$11.75 - $21.42 $75,529 - $137,687	-6,428 Reduced 2.6%	240,488 $3.05 Million
Q3 2018 Nov 13, 2018	BUY	$19.26 - $23.46 $133,375 - $162,460	6,925 Added 2.89%	246,916 $5.29 Million
Q2 2018 Aug 15, 2018	BUY	$19.78 - $24.67 $409,980 - $511,335	20,727 Added 9.45%	239,991 $4.96 Million
Q1 2018 May 14, 2018	BUY	$18.89 - $32.46 $828,628 - $1.42 Million	43,866 Added 25.01%	219,264 $5.52 Million
Q4 2017 Feb 12, 2018	BUY	$16.19 - $20.3 $2.84 Million - $3.56 Million	175,398	175,398 $3.33 Million

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

Bellevue Group Ag Kuesnacht, V8

9.93M
Shares

$32.1 Million
0.55% of portfolio
Armistice Capital, LLC New York, NY

6.26M
Shares

$20.2 Million
0.34% of portfolio
Black Rock Inc. New York, NY

5.4M
Shares

$17.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.36M
Shares

$14.1 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.54M
Shares

$11.4 Million
0.01% of portfolio

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $199M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Account